Compare ETFs: THNR
THNR
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| THNR | 4.57% | 15.86% | - | - | 3.71% |
Top 25 Holdings
| THNR - Amplify Weight Loss Drug & Treatment ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | NVO | Novo Nordisk A/S | 13.98% |
| 2 | LLY | Eli Lilly and Company | 11.94% |
| 3 | AMGN | Amgen Inc. | 6.82% |
| 4 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 6.35% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 6.32% |
| 6 | TYO: 4507 | Shionogi & Co., Ltd. | 5.54% |
| 7 | SWX: ROG | Roche Holding AG | 5.34% |
| 8 | MRK | Merck & Co., Inc. | 5.18% |
| 9 | AZN | AstraZeneca PLC | 4.85% |
| 10 | PFE | Pfizer Inc. | 4.80% |
| 11 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.73% |
| 12 | ABBV | AbbVie Inc. | 4.65% |
| 13 | HKG: 1801 | Innovent Biologics, Inc. | 4.57% |
| 14 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.98% |
| 15 | HIMS | Hims & Hers Health, Inc. | 2.79% |
| 16 | CPH: ZEAL | Zealand Pharma A/S | 1.91% |
| 17 | SRRK | Scholar Rock Holding Corporation | 1.63% |
| 18 | VKTX | Viking Therapeutics, Inc. | 1.52% |
| 19 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 1.03% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 0.98% |
| 21 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H | 0.91% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.18% |
| 23 | n/a | n/a | n/a |
| 24 | n/a | n/a | n/a |
| 25 | n/a | n/a | n/a |
| View THNR holdings | |||